US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist

706.940
-16.530-2.28%

Close Feb 26 16:00 ET

706.940
0.0000.00%

Post 20:01 ET

77.29BMarket Cap18.44P/E (TTM)

Regeneron Pharmaceuticals Stock Forum

Teddy123

13 hours ago

Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma

$Regeneron Pharmaceuticals (REGN.US)$
Can Regeneron's Cancer Drug With 80% Response Rate Secure FDA Approval For Lymphoma?

$Odronextamab BLA Accepted for FDA Review for the Treatment of Relapsed/Refractory Follicular Lymphoma$

Teddy123

Feb 25 00:11

Latest DB-OTO Results Demonstrate Clinically Meaningful Hearing Improvements in Nearly All Children with Profound Genetic Hearing Loss in CHORD Trial

$Regeneron Pharmaceuticals (REGN.US)$
Revolutionary Hearing Breakthrough: Can This Gene Therapy End Childhood Genetic Deafness?

TRIUMPHANT RETURNS

Feb 18 16:38

LOTS OF NOTABLE NAMES IN THIS STOCK!

$Novo-Nordisk A/S (NVO.US)$ $Moderna (MRNA.US)$ $Johnson & Johnson (JNJ.US)$ $Netflix (NFLX.US)$ $Uber Technologies (UBER.US)$ $Grab Holdings (GRAB.US)$ $ParkwayLife Reit (C2PU.SG)$ $Tempus AI (TEM.US)$ $Serve Robotics (SERV.US)$ $Tesla (TSLA.US)$ $Regeneron Pharmaceuticals (REGN.US)$ $Amgen (AMGN.US)$

Share Your Profit/Loss

韭菜变主力

Feb 4 10:54

$Regeneron Pharmaceuticals (REGN.US)$ In traditional technical analysis, you would think this is likely reversed given the engulfing pattern with strong volume at an earnings event. But in this trending market, a higher high has to be established.

10xStockPicks

Jan 23 07:47

Today 3 Analysts Place BUY Ratings On This $2 Stock $7,$9 & $16 Which Is An Acquisition Target by BIG Pharma

$Esperion Therapeutics (ESPR.US)$ Jan 23, 2025 Three analysts are bullish on Esperion Therapeutics with price targets on this $2 stock ranging from $7 to $16 a share.
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...

韭菜变主力

Jan 13 16:45

$Regeneron Pharmaceuticals (REGN.US)$ Wow, that was a nice dip buying. I didn’t follow their events closely. I bought back somewhat early on Jan 10.

韭菜变主力

Jan 10 13:12

$Regeneron Pharmaceuticals (REGN.US)$ It’s doing this kind of thing. Kind of scary. Nobody wants it for above 700.

韭菜变主力

Jan 7 23:51

$Regeneron Pharmaceuticals (REGN.US)$ This is in NDX and could benefit from the weakness of mega-cap tech stocks in the index.

韭菜变主力

Dec 31 16:47

$Regeneron Pharmaceuticals (REGN.US)$Nice. It’s quiet here and just broke the steep down trend.

10xStockPicks

Dec 15, 2024 18:30

A.i Predicts Big Pharma Will Soon Acquire Esperion Therapeutics for $12 to $16 A share, Current Price $2.25

$Esperion Therapeutics (ESPR.US)$ Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry:
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...